Alliance Pharma, the Chippenham-based speciality pharmaceutical group, has expanded its portfolio by paying £2.4m to acquire the UK marketing rights to six products from Beacon Pharmaceuticals. In the year to April 30 the products had total sales of approximately £2m and gross margin of £900,000, mainly from severe acne treatment Rizuderm (isotretinoin) which fits...